This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Henry Ford Health System, University of Michigan. Active years: 1997.
Company Filing History:
1 out of 81 
1 out of 3,523 
Years Active: 1997
Title: The Innovations of Daniel T Eitzman
Introduction
Daniel T Eitzman is a notable inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of medical science, particularly in the area of thrombolysis. His work focuses on the development of peptides that enhance the effectiveness of clot lysis, which is crucial for treating various medical conditions.
Latest Patents
Daniel T Eitzman holds 1 patent for his invention titled "Peptide mediated enhancement of thrombolysis methods and compositions." This invention relates to peptides that decrease the half-life of active plasminogen activator inhibitor-1. The methods and compositions he developed are aimed at improving clot lysis, which can have a profound impact on patient care in thrombolytic therapy.
Career Highlights
Throughout his career, Eitzman has worked with prestigious institutions such as the University of Michigan and Henry Ford Health System. His research has contributed to advancements in medical treatments and has been recognized within the scientific community.
Collaborations
Daniel T Eitzman has collaborated with notable colleagues, including Daniel Lawrence and David Ginsburg. These partnerships have furthered his research and innovation in the medical field.
Conclusion
Daniel T Eitzman is a distinguished inventor whose work in peptide-mediated thrombolysis has the potential to enhance medical treatments significantly. His contributions to science and medicine continue to pave the way for future innovations.